Tianjin Life Science Research Center, Tianjin Key Laboratory of Inflammation Biology, Collaborative Innovation Center of Tianjin for Medical Epigenetics, Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 30070, China.
Viruses. 2020 Mar 21;12(3):346. doi: 10.3390/v12030346.
The tripartite motif (TRIM) protein family is an E3 ubiquitin ligase family. Recent reports have indicated that some TRIM proteins have antiviral functions, especially against retroviruses. However, most studies mainly focus on the relationship between TRIM21 and interferon or other antiviral effectors. The effect of TRIM21 on virus-encoded proteins remains unclear. In this study, we screened candidate interacting proteins of HBV DNA polymerase (Pol) by FLAG affinity purification and mass spectrometry assay and identified TRIM21 as its regulator. We used a coimmunoprecipitation (co-IP) assay to demonstrate that TRIM21 interacted with the TP domain of HBV DNA Pol. In addition, TRIM21 promoted the ubiquitination and degradation of HBV DNA Pol using its RING domain, which has E3 ubiquitin ligase activity. Lys260 and Lys283 of HBV DNA Pol were identified as targets for ubiquitination mediated by TRIM21. Finally, we uncovered that TRIM21 degrades HBV DNA Pol to restrict HBV DNA replication, and its SPRY domain is critical for this activity. Taken together, our results indicate that TRIM21 suppresses HBV DNA replication mainly by promoting the ubiquitination of HBV DNA Pol, which may provide a new potential target for the treatment of HBV.
三结构域蛋白(TRIM)家族是一种 E3 泛素连接酶家族。最近的报道表明,一些 TRIM 蛋白具有抗病毒功能,特别是针对逆转录病毒。然而,大多数研究主要集中在 TRIM21 与干扰素或其他抗病毒效应子之间的关系上。TRIM21 对病毒编码蛋白的影响尚不清楚。在本研究中,我们通过 FLAG 亲和纯化和质谱分析筛选了 HBV DNA 聚合酶(Pol)的候选相互作用蛋白,并鉴定出 TRIM21 是其调节因子。我们使用共免疫沉淀(co-IP)实验证明了 TRIM21 与 HBV DNA Pol 的 TP 结构域相互作用。此外,TRIM21 利用其具有 E3 泛素连接酶活性的 RING 结构域促进了 HBV DNA Pol 的泛素化和降解。HBV DNA Pol 的 Lys260 和 Lys283 被鉴定为 TRIM21 介导的泛素化的靶标。最后,我们发现 TRIM21 通过降解 HBV DNA Pol 来抑制 HBV DNA 复制,其 SPRY 结构域对该活性至关重要。总之,我们的研究结果表明,TRIM21 主要通过促进 HBV DNA Pol 的泛素化来抑制 HBV DNA 复制,这可能为治疗 HBV 提供一个新的潜在靶点。